Skip to content

Cola for Oesophageal Food Bolus Impaction (Cola Trial)

Cola for Oesophageal Food Bolus Impaction (Cola Trial) - Cola Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON50563
Enrollment
50
Registered
2019-06-03
Start date
2019-12-22
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

food bolus in oesophagus Oesophageal food bolus impaction

Interventions

Canned Coca-Cola will be kept in the refrigerator of the Emergency Department. For every new patient, a new can will be opened. The patient will be given a bowl or will be placed by the sink because

Sponsors

AMC Amsterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Presence of a complete oesophageal food bolus impaction - Impaction of soft food (boneless) - Age >17 years - Signed written informed consent - ASA class I, II or III

Exclusion criteria

Exclusion criteria: - A trial of cola or another carbonated beverage before coming to hospital - Other pre-endoscopic treatment having been given in-hospital or pre-hospital (such as nifedipine, glucagon, nitrates, butyl scopolamine, benzodiazepines, calcium channel blockers or other) - Impaction of non-food items or food known to contain bones or fish bones - Visible food bolus upon oral inspection - Significant aspiration risk: reduced consciousness (GCS

Design outcomes

Primary

MeasureTime frame
Improvement of oesophageal food bolus obstruction, defined as either complete or partial resolution: Complete resolution: - Complete symptom resolution and - The ability to swallow saliva. Partial resolution: - Improvement in symptoms, but not disappearance and - The ability to swallow saliva.

Secondary

MeasureTime frame
Intervention complications, defined as: - oesophageal perforation or - mucosal laceration or - bleeding or - aspiration or - any other complication requiring treatment, leading to a prolonged ED stay or requiring hospitalization.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)